Lipocine (NASDAQ:LPCN) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 121.43 percent decrease over earnings of $0.14 per share from the same period last year.
Top 3 Materials Stocks That Are Preparing To Pump In Q2
The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
